Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)

Recruiting now · Not applicable

Conditions studied: Mobile Health, Medication Management, Drug Labelling

In brief

The goal of this cluster randomized trial is to learn if eDrugSafe, a mobile web platform for drug electronic labeling (e-labeling) and medication management, can improve medication adherence and self-efficacy in adults who take multiple medications. This study will also assess whether eDrugSafe is feasible and acceptable for use in real clinical settings, especially in local pharmacies. The main questions it aims to answer are: * Can eDrugSafe improve medication adherence, self-efficacy, and quality of life for adults taking multiple medications and reduce hospitalizations? * Is eDrugSafe acceptable and feasible for implementing drug e-labeling and supporting medication management in community settings? Researchers will compare eDrugSafe to usual care (traditional paper methods) to see if eDrugSafe is effective in supporting adults who take multiple medications, and if it can be feasibly implemented in local pharmacies. Participants will: * Visit a local pharmacy randomly assigned to use eDrugSafe or traditional care methods and decide if they wish to join the study. * Use either eDrugSafe to access medication information and manage their medication history, or receive usual care with paper-based methods, for 6 months. * Complete surveys at the start of the study, at 3 months, and at 6 months to measure effectiveness and implementation outcomes.

Key facts

Study ID

NCT06703697

Run by

Seoul National University

People needed

360

Starts

2024-08-12

Expected to finish

2025-07-31

Last updated by the study team

2024-11-27

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults aged 18 to 79 years.
• Individuals who can speak and understand Korean.
• Possession of a personal electronic device capable of accessing mobile applications and web services over wireless internet (bring participants' own device, BYOD).
• Patients taking three or more medications with at least one medication prescribed for 28 days or longer.
• Individuals who have provided direct consent to participate in the study.

You may not qualify if…

• Individuals using any mobile web platform other than eDrugSafe for medication safety information purposes after enrollment.
• Individuals who do not consent to participate in the study or who withdraw their consent.

Where it is running

• Seoul National University — Seoul, Gwanak-gu, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.